Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$272,187
-$99,127 QoQ
Shares Held
47,173
-5.6% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 31 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. ALGS ranks #389 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ALGS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $272,187 47,173
2026-03-31 $371,314 49,975
2025-12-31 $444,945 47,741
2025-09-30 $461,383 47,080
2025-06-30 $245,485 34,048
2025-03-31 $231,577 28,070
2024-12-31 $1,085,758 27,253
2024-09-30 $208,324 24,056
2024-06-30 $141,992 405,694
2024-03-31 $365,594 373,056
2023-12-31 $213,173 321,044
2023-09-30 $180,402 241,503
2023-06-30 $249,150 256,592
2023-03-31 $174,675 199,858
2022-12-31 $190,464 199,858
2022-09-30 $209,459 190,418
2022-06-30 $230,405 190,418
2022-03-31 $762,792 354,787
2021-12-31 $4,149,467 349,576
2021-09-30 $4,864,789 313,655
2021-06-30 $5,205,268 255,348
2021-03-31 $4,064,820 178,752
2020-12-31 $4,940,889 178,694